logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10150773 B1

PDFFull Text
Expired
Date of Patent:
Dec. 11, 2018

Filed:

Feb. 02, 2016

N-substituted 8-[(2,6-difluorobenzyl)oxy]-2,6- dimethylimidazo[1,2-a]pyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cyclase (sgc) for the treatment of cardiovascular diseases

Applicant:

Bayer Pharma Aktiengesellschaft, Berlin, DE;

Inventors:

Alexandros Vakalopoulos, Hilden, DE;

Damian Brockschnieder, Haan, DE;

Frank Wunder, Wuppertal, DE;

Johannes-Peter Stasch, Grottaferrata, IT;

Tobias Marquardt, Wuppertal, DE;

Lisa Dietz, Wuppertal, DE;

Min Jian Volkhart Li, Velbert, DE;

Assignee:

Bayer Pharma Aktiengesellschaft, Berlin, DE;

Attorney:

Ice Miller LLP

Primary Examiner:

Brian E McDowell

Int. Cl.
CPC ...
C07D 487/04 (2006.01); A61K 31/4985 (2006.01); A61K 31/695 (2006.01); A61K 45/06 (2006.01); C07B 59/00 (2006.01); C07F 7/08 (2006.01);
U.S. Cl.
CPC ...
C07D 487/04 (2013.01); A61K 31/4985 (2013.01); A61K 31/695 (2013.01); A61K 45/06 (2013.01); C07B 59/002 (2013.01); C07F 7/0812 (2013.01); C07B 2200/05 (2013.01);
Abstract

The present application relates to novel substituted imidazo[1,2-a]pyrazine carboxamides of general formula (I) to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.

Find Patent Forward Citations

Vakalopoulos, Alexandros. (2018). N-substituted 8-[(2,6-difluorobenzyl)oxy]-2,6- dimethylimidazo[1,2-a]pyrazin-3-carboxamide derivatives as stimulators of soluble guanylate cyclase (sgc) for the treatment of cardiovascular diseases (U.S. Patent No. 10150773). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10150773

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…